Company
Bionl
Pan.bio is the AI-powered, end-to-end genomics platform connecting bioinformatics workflows, variant interpretation, and patient cohort data, all in one place.
Also known as Bionl, Inc, Pan.bio
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Boston, MA, United States
- Customers
- For hospitals, clinical labs, pharma R&D, and institutions with compliance or sovereignty requirements.
- Legal name
- Bionl, Inc
- bionl.ai (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
Pan.bio exists to empower scientists to transform genomic data into scientific breakthroughs. We build the AI-powered, end-to-end platform that bridges the distance between raw sequences and world-changing insights, making genomic research faster, more accurate, and accessible to teams who've been left out of the global research conversation for too long.
Loading relationship preview